WASHINGTON, DC and PASADENA, CA--(Marketwire - September 18, 2008) - Today BARDA announced the award of Contract BAA-BARDA-08-08 to Neumedicines Inc. for the development of a therapeutic solution for the hematopoietic syndrome resulting from exposure to acute ionizing radiation.
